Walvax BioTech (300142) — Capital Reinvestment Ratio
Walvax BioTech (300142) has a Capital Reinvestment Ratio of 0.26x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥278.33 Million) in capital expenditures (CN¥71.03 Million). See debt-free asset ratio of Walvax BioTech to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Walvax BioTech Capital Reinvestment Ratio (2007–2025)
This chart tracks Walvax BioTech's Capital Reinvestment Ratio across 12 annual periods. Check how aggressively does Walvax BioTech reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Walvax BioTech (2007–2025)
Year-by-year Capital Reinvestment Ratio for Walvax BioTech from 2007 to 2025. For live market cap and broader valuation context, see how much is Walvax BioTech worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.03x | CN¥494.37 Million | CN¥509.54 Million | ▲ +94.2% |
| 2024 | 0.53x | CN¥1.04 Billion | CN¥550.03 Million | ▼ -36.4% |
| 2023 | 0.83x | CN¥1.13 Billion | CN¥945.52 Million | ▼ -8.2% |
| 2022 | 0.91x | CN¥1.20 Billion | CN¥1.09 Billion | ▼ -42.0% |
| 2021 | 1.56x | CN¥705.28 Million | CN¥1.10 Billion | ▼ -56.1% |
| 2020 | 3.57x | CN¥114.19 Million | CN¥407.13 Million | ▼ -37.2% |
| 2019 | 5.67x | CN¥62.02 Million | CN¥351.82 Million | ▲ +24.9% |
| 2012 | 4.54x | CN¥78.38 Million | CN¥355.87 Million | ▲ +111.4% |
| 2011 | 2.15x | CN¥91.98 Million | CN¥197.56 Million | ▲ +13.0% |
| 2010 | 1.90x | CN¥86.71 Million | CN¥164.81 Million | ▲ +109.0% |
| 2009 | 0.91x | CN¥82.18 Million | CN¥74.75 Million | ▲ +58.7% |
| 2007 | 0.57x | CN¥31.85 Million | CN¥18.26 Million | — |